PRADAXA 150 mg, hard capsule 60 capsules
Brand page: Pradaxa (dabigatran etexilate) — all forms and strengths in France
Active ingredients: DABIGATRAN ÉTEXILATE (MÉSILATE DE), DABIGATRAN ÉTEXILATE BASE
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule60 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PRADAXA 150 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 60 plaquette(s) thermoformée(s) aluminium de 1 gélule(s)
- Marketing authorisation holder
- BOEHRINGER INGELHEIM INTERNATIONAL
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Prévention des accidents vasculaires cérébraux et des embolies systémiques en cas de fibrillation atriale non valvulaire associée à certain(s) facteur(s) de risque (adultes) ; JOURNAL OFFICIEL ; 19/07/12
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 May 2012
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63484283CIP74194538CIP133400941945380Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DABIGATRAN ÉTEXILATE BASEgélule | 150 mg · un comprimé | FT |
| DABIGATRAN ÉTEXILATE (MÉSILATE DE)gélule | 172,95 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: DABIGATRAN ETEXILATE (MESILATE DE) équivalant à DABIGATRAN ETEXILATE 150 mg - PRADAXA 150 mg, gélule